Divovain Ka Jenerik Varjan America Mein Launch Kar Sakti Hai Rainabaiksi

Business »

Divovain Ka Jenerik Varjan America Mein Launch Kar Sakti Hai Rainabaiksi

[ soma das | nai Delhi ] lambe samay se reguletari mushkilein jhelne ke baad rainabaiksi laiboretareej Switzerland ki pharma company novaartis ki blood preshar ko control karne waali dava divovain ka ameriki market mein jenerik varjan launch karne ke kareeb pahunch sakti hai. Company ke paas America mein is dava ke liye 180 dinon ki eksakloosiv maarketing ka mauka hai. Is divelapameint ki jaankaari rakhane vaale ek vyakti ne bataaya ki launch May ki shuruaat mein ho sakta hai. Novaartis ke paas is dava ke liye peteint September 2012 mein samaapt ho gaya tha. Ek industry egjikyootiv ne kaha ki rainabaiksi ne shaayad iske liye ektiv pharma ingreediyent (epeeaai) haasil karne ke maksad se Hyderabad ki diveej laibs se egreemeint kiya hai. Kisi dava ko banaane ke liye epeeaai mukhya rau maiteeriyl hota hai. Unka kehna tha, 'Faurmyooleshans America mein rainabaiksi ke ohm laibs plant mein banaai jaaengi aur thard party America mein epeeaai bhejegi. ' is baare mein rainabaiksi ke pravakta ne koi tippani karne se inkaar kar diya. Rainabaiksi ke CEO arun saahani ne is maheene ki shuruaat mein ek conference call mein kaha tha ki company ko vishvaas hai ki vah America mein eksakloosiviti ke mauke barkaraar rakhegi aur unase revenyoo haasil karegi. Isi maheene Mumbai ki san pharma ne 4 arab dollar mein rainabaiksi ka ekvijishn karne ki ghoshana ki thi. Marjan ke baad sanyukt company desh mein sabse badi aur duniya mein paanchavi sabse badi jenerik dava company ban jaaegi. Rainabaiksi ki paireint daaichi sainkyo nai company mein 9 feesadi hissedaari barkaraar rakhegi. HSBC ne January mein ek research not mein kaha tha ki rainabaiksi agar is dava ko braanded varjan se 40 se 50 feesadi diskaaunt par launch karti hai aur America mein iska aadha market share haasil kar leti hai to chhah maheene ke eksakloosiviti peeriyd mein company 20 karod dollar ka revenyoo haasil kar sakti hai. Haalaanki iske kuchh dinon baad hi rainabaiksi ke Punjab ke toaansa mein maujood epeeaai plant par America ko eksaport karne par ban lag gaya. Ab kisi baahari party se epeeaai ki sorsing karne par rainabaiksi ko sales ka kuchh hissa share karna padega. Eksakloosiviti peeriyd ke dauraan koi anya company iska jenerik varjan launch naheen kar sakti. Is baare mein diveej lab ne ikanaumik times ki imel ka koi javaab naheen diya. Company ki website se pata chalta hai ki isne vailasaartan ke liye epeeaai par yooesaefadeee ko 2011 mein reguletari jaankaari di thi. Novaartis ko is dava se duniyaabhar mein lagbhag 3.4 arab dollar ka revenyoo milta hai. Company ko rainabaiksi ke is dava ka jenerik varjan abhi tak launch na kar paane ki vajah se faayda mila hai. Isne pichhle varsh jenerik kaumpitishn ki kami ki vajah se sales doguni hone ka anumaan jataaya tha.

Divovain Ka Jenerik Varjan America Mein Launch Kar Sakti Hai Rainabaiksi http://www.angrejinews.com/pic/48535